APLT
Price
$0.45
Change
+$0.04 (+9.76%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
47.72M
34 days until earnings call
EDIT
Price
$1.04
Change
-$0.08 (-7.14%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
93.35M
26 days until earnings call
Ad is loading...

APLT vs EDIT

Header iconAPLT vs EDIT Comparison
Open Charts APLT vs EDITBanner chart's image
Applied Therapeutics
Price$0.45
Change+$0.04 (+9.76%)
Volume$115.15K
Capitalization47.72M
Editas Medicine
Price$1.04
Change-$0.08 (-7.14%)
Volume$39.16K
Capitalization93.35M
APLT vs EDIT Comparison Chart
Loading...
APLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APLT vs. EDIT commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APLT is a Buy and EDIT is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 05, 2025
Stock price -- (APLT: $0.41 vs. EDIT: $1.12)
Brand notoriety: APLT and EDIT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APLT: 85% vs. EDIT: 48%
Market capitalization -- APLT: $47.72M vs. EDIT: $93.35M
APLT [@Biotechnology] is valued at $47.72M. EDIT’s [@Biotechnology] market capitalization is $93.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APLT’s FA Score shows that 0 FA rating(s) are green whileEDIT’s FA Score has 1 green FA rating(s).

  • APLT’s FA Score: 0 green, 5 red.
  • EDIT’s FA Score: 1 green, 4 red.
According to our system of comparison, EDIT is a better buy in the long-term than APLT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APLT’s TA Score shows that 5 TA indicator(s) are bullish while EDIT’s TA Score has 2 bullish TA indicator(s).

  • APLT’s TA Score: 5 bullish, 4 bearish.
  • EDIT’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, APLT is a better buy in the short-term than EDIT.

Price Growth

APLT (@Biotechnology) experienced а -24.48% price change this week, while EDIT (@Biotechnology) price change was -13.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.29%. For the same industry, the average monthly price growth was -17.13%, and the average quarterly price growth was -18.92%.

Reported Earning Dates

APLT is expected to report earnings on May 08, 2025.

EDIT is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Biotechnology (-11.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EDIT($93.3M) has a higher market cap than APLT($47.7M). EDIT YTD gains are higher at: -11.811 vs. APLT (-52.102). APLT has higher annual earnings (EBITDA): -91.93M vs. EDIT (-233.11M). EDIT has more cash in the bank: 270M vs. APLT (98.9M). APLT has less debt than EDIT: APLT (1.97M) vs EDIT (35M). EDIT has higher revenues than APLT: EDIT (32.3M) vs APLT (-212K).
APLTEDITAPLT / EDIT
Capitalization47.7M93.3M51%
EBITDA-91.93M-233.11M39%
Gain YTD-52.102-11.811441%
P/E RatioN/AN/A-
Revenue-212K32.3M-1%
Total Cash98.9M270M37%
Total Debt1.97M35M6%
FUNDAMENTALS RATINGS
APLT vs EDIT: Fundamental Ratings
APLT
EDIT
OUTLOOK RATING
1..100
7161
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
19
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
9594
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EDIT's Valuation (19) in the Biotechnology industry is somewhat better than the same rating for APLT (68) in the null industry. This means that EDIT’s stock grew somewhat faster than APLT’s over the last 12 months.

EDIT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as APLT (100) in the null industry. This means that EDIT’s stock grew similarly to APLT’s over the last 12 months.

EDIT's SMR Rating (98) in the Biotechnology industry is in the same range as APLT (100) in the null industry. This means that EDIT’s stock grew similarly to APLT’s over the last 12 months.

EDIT's Price Growth Rating (94) in the Biotechnology industry is in the same range as APLT (95) in the null industry. This means that EDIT’s stock grew similarly to APLT’s over the last 12 months.

EDIT's P/E Growth Rating (100) in the Biotechnology industry is in the same range as APLT (100) in the null industry. This means that EDIT’s stock grew similarly to APLT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APLTEDIT
RSI
ODDS (%)
Bullish Trend 2 days ago
79%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 19 days ago
88%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
73%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
APLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RSNVF0.05N/A
+2.04%
Reyna Silver Corp.
DBSDY135.26-2.82
-2.04%
DBS Group Holdings Ltd.
ZLNDY17.67-0.48
-2.66%
ZALANDO SE
SCGLY8.51-0.39
-4.33%
Societe Generale
FECCF4.37-0.22
-4.79%
Frontera Energy Corp

APLT and

Correlation & Price change

A.I.dvisor indicates that over the last year, APLT has been loosely correlated with AMGXF. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if APLT jumps, then AMGXF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APLT
1D Price
Change %
APLT100%
-7.01%
AMGXF - APLT
33%
Loosely correlated
N/A
TNFA - APLT
28%
Poorly correlated
+0.02%
COEP - APLT
27%
Poorly correlated
+2.85%
BPMC - APLT
27%
Poorly correlated
-3.22%
EDIT - APLT
25%
Poorly correlated
-5.08%
More

EDIT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EDIT has been loosely correlated with AXON. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if EDIT jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDIT
1D Price
Change %
EDIT100%
-5.08%
AXON - EDIT
52%
Loosely correlated
-3.35%
CRSP - EDIT
50%
Loosely correlated
-4.47%
VCYT - EDIT
49%
Loosely correlated
-5.51%
PRME - EDIT
48%
Loosely correlated
-10.06%
ARRY - EDIT
47%
Loosely correlated
-10.32%
More